Full Text View
Tabular View
No Study Results Posted
Related Studies
An Investigational Drug Study With Suberoylanilide Hydroxamic Acid in Relapsed Diffuse Large B-cell Lymphoma (0683-013)
This study has been completed.
Study NCT00097929   Information provided by Merck Sharp & Dohme Corp.

First Received on December 1, 2004.   Last Updated on November 14, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial